Avidity Partners Management LP
Top Portfolio Positions
52 positions ·
$504,281,336 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
2,104,184 | $176,583,121 | 35.02% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
1,288,948 | $87,236,000 | 17.30% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
760,424 | $37,298,797 | 7.40% | |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
6,049,999 | $25,228,495 | 5.00% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
1,400,708 | $19,679,947 | 3.90% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
400,000 | $15,680,000 | 3.11% | |
| TEVA |
Teva Pharmaceutical Industries Ltd
Healthcare
|
450,100 | $13,557,012 | 2.69% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
4,998,267 | $13,095,459 | 2.60% | |
| RGEN |
Repligen Corp
Healthcare
|
77,800 | $9,166,396 | 1.82% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
70,000 | $8,725,500 | 1.73% |
Portfolio Trend
25 quarters · across all stocks
Holdings in PHAT
Shares Held
Position Value (USD)
19 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,770,722 | 249,390 | Shares | Sole | 2026-05-28 | |
| 2025-12-31 | $3,418,800 | 206,076 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,601,620 | 306,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,208,555 | 1,064,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,016,000 | 800,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,287,612 | 1,390,100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $32,625,233 | 1,804,493 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,686,000 | 1,620,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,425,700 | 1,735,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $15,718,025 | 1,721,580 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,771,401 | 1,617,300 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $27,919,704 | 1,949,700 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,627,004 | 2,048,600 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $21,318,000 | 1,900,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,127,344 | 1,906,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,203,112 | 1,919,800 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $26,485,060 | 1,946,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $37,294,320 | 1,896,000 | Shares | Sole | 2022-02-14 | |
| 2020-12-31 | $5,066,050 | 152,500 | Shares | Sole | 2021-02-16 | |
| No 13F history on record for this holder in this stock. | ||||||